Inhibition of endoplasmic reticulum stress and oxidative stress by vitamin D in endothelial cells

Free Radic Biol Med. 2016 Oct:99:1-10. doi: 10.1016/j.freeradbiomed.2016.07.020. Epub 2016 Jul 22.

Abstract

Endoplasmic reticulum (ER) stress and oxidative stress promote endothelial dysfunction and atherosclerosis. Since vitamin D has been shown in several studies to lower the risk of cardiovascular disease, we examined the effects of vitamin D on ER stress and oxidative stress in endothelial cells. ER stress was measured using the placental secreted alkaline phosphatase assay and oxidative stress was measured by hydroethidine fluorescence. Expression of ER stress markers, including glucose-regulated protein 78, c-jun N-terminal kinase 1 phosphorylation, and eukaryotic initiation factor 2α phosphorylation, as well as X-box binding protein-1 splicing were measured in tunicamycin (TM)-treated human umbilical endothelial cells (HUVEC) treated with 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) and other vitamin D analogs. When TM and 1,25-(OH)2D3 were added simultaneously, 1,25-(OH)2D3 prevented ER stress. However, the effect was much stronger when cells were pre-treated with 1,25-(OH)2D3 for 24-h. However, ER stress was not inhibited by 25-OH vitamin D3 (25-OHD3) or the vitamin D analog EB1089. Both ZK191784 and the vitamin D metabolite 24,25-dihydroxyvitamin D3 were as effective as 1,25-(OH)2D3 in preventing ER stress. Similar effects were observed dextrose-induced stress. All of the compounds tested, except for 25-OHD3, inhibited dextrose-induced (27.5mM) oxidative stress and ER stress. Although TM with and without 1,25-(OH)2D3 had no effect on VDR expression, inhibition of VDR expression via siRNA prevented 1,25-(OH)2D3, ZK191784, EB1089, and 24,25-dihydroxyvitamin D3 from inhibiting dextrose-mediated SO generation. Furthermore, each vitamin D analog, with the exception of 25-OHD3, prevented dextrose-induced toxicity. These results suggest that vitamin D has a protective effect on vascular endothelial cells.

Keywords: 1,25-dihydroxyvitamin D(3); Cardiovascular disease; Endoplasmic reticulum stress; Endothelial cells.

MeSH terms

  • 24,25-Dihydroxyvitamin D 3 / pharmacology*
  • Antioxidants / pharmacology*
  • Biomarkers / metabolism
  • Calcitriol / analogs & derivatives
  • Calcitriol / pharmacology*
  • Cell Survival / drug effects
  • Endoplasmic Reticulum Chaperone BiP
  • Endoplasmic Reticulum Stress / drug effects*
  • Eukaryotic Initiation Factor-2 / genetics
  • Eukaryotic Initiation Factor-2 / metabolism
  • Gene Expression
  • Glucose / antagonists & inhibitors
  • Glucose / pharmacology
  • Heat-Shock Proteins / genetics
  • Heat-Shock Proteins / metabolism
  • Human Umbilical Vein Endothelial Cells / cytology
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • JNK Mitogen-Activated Protein Kinases / genetics
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Oxidative Stress / drug effects*
  • Phosphorylation
  • Receptors, Calcitriol / genetics
  • Receptors, Calcitriol / metabolism
  • Tunicamycin / antagonists & inhibitors
  • Tunicamycin / pharmacology
  • Vitamin D / analogs & derivatives
  • Vitamin D / pharmacology
  • X-Box Binding Protein 1 / genetics
  • X-Box Binding Protein 1 / metabolism

Substances

  • Antioxidants
  • Biomarkers
  • Endoplasmic Reticulum Chaperone BiP
  • Eukaryotic Initiation Factor-2
  • Heat-Shock Proteins
  • Receptors, Calcitriol
  • VDR protein, human
  • X-Box Binding Protein 1
  • ZK 191784
  • Tunicamycin
  • Vitamin D
  • 24,25-Dihydroxyvitamin D 3
  • 25-hydroxyvitamin D
  • JNK Mitogen-Activated Protein Kinases
  • Calcitriol
  • Glucose
  • seocalcitol